Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
⏸️ Investing
Should you buy these 3 blue-chip beauties?
⏸️ Investing
Your ready to go, instant 6-share balanced portfolio
⏸️ Investing
Build your own family dynasty with these 4 wealth creators
⏸️ Investing
4 reasons why playing Monopoly can help your investing
⏸️ Investing
Is Cochlear Limited's new hybrid device a turning point?
⏸️ Investing
Which are the best healthcare stocks to buy now?
⏸️ Investing
What now for Cochlear Limited?
⏸️ Investing
3 healthcare stocks with growing dividends
⏸️ Investing
ResMed Inc, Cochlear Limited, Coca-Cola Amatil Ltd: 3 bargain blue chips
⏸️ Investing
Cochlear Limited shares drop 9.8% after results release – here's what you need to know
⏸️ Investing
3 bargain blue chips
⏸️ Investing
The stock picker's guide to Cochlear Limited
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
